Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies.
Saved in:
| Title: | Reassessing cancer risk with GLP-1 receptor agonists: a comprehensive meta-analysis of gastrointestinal malignancies. |
|---|---|
| Authors: | Wali AF; RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates., Rangraze I; Department of Internal Medicine, RAK College of Medical Sciences, RAK Medical and Health Sciences, Ras AlKhaimah, United Arab Emirates., Khan S; Department of Psychiatry, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates., Mufti UB; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., El-Tanani M; RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras AlKhaimah, United Arab Emirates., Rizzo M; Department of Internal Medicine, RAK College of Medical Sciences, RAK Medical and Health Sciences, Ras AlKhaimah, United Arab Emirates.; School of Medicine, PROMISE Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medicinal Specialties, University of Palermo, Palermo, Italy. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Feb 10; Vol. 17, pp. 1736380. Date of Electronic Publication: 2026 Feb 10 (Print Publication: 2026). |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1736380 |
